PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

This activity was originally presented at the 2025 Community Oncology Conference in Lake Buena Vista, Florida on April 30, 2025.

Target audience: Oncology pharmacists and specialty pharmacists

Type of activity: Knowledge
Release date: May 6, 2026
Expiration date: May 6, 2026

Time to complete activity: 0.75 hour

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Define PBM Practices and their Impact – Explain steerage, discuss current reimbursement challenges, and legal actions affecting medically integrated dispensing (MID) pharmacies
• Discuss status of COA public arbitrations - briefly review what has happened and future implications
• Examine Legal and Regulatory Trends - state-driven policies governing pharmacy regulations, licensing variations, and the implications for MIDs/physician-owned practices
• Illustrate oncology pharmacists integration into patient care - discuss the role of pharmacists in clinical decision-making, and strategies to strengthen community oncology teams
• Explore reasons PBM reform absent from End Of Year (EOY) package - conclusions and predictions for PBM reform and pharmacist integration

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-25-135-H03-P. The activity is available for CE credit through May 6, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Jonathan E. Levitt, JD

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Amy L. Morris, PharmD, BCOP; Daphne Davis, PharmD, BCOP; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.


Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms